These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3275150)

  • 1. Folic acid instead of leucovorin for 5-FU modulation?
    Ratner LH
    Oncology (Williston Park); 1988 Jan; 2(1):46. PubMed ID: 3275150
    [No Abstract]   [Full Text] [Related]  

  • 2. [A clinical study of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for liver metastases].
    Ichihara T; Tenma K; Itoh M; Hibino M; Kikuchi I; Sasaki Y; Hosono Y; Nakamura M
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1143-5. PubMed ID: 12938270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological study on levofolinate in intraperitoneal leucovorin-5-FU chemotherapy].
    Maruyama M; Ebuchi M; Nagahama T; Takashima I; Hasegawa K; Ochiai T; Natsui S
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2199-201. PubMed ID: 12484036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination of levofolinate calcium and 5-fluorouracil].
    Sasaki T
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):315-22. PubMed ID: 10700909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of the treatment of gastric cancer as neo-adjuvant chemotherapy of 48 hour continuous intravenous infusion of 5-fluorouracil (5-FU) with leucovorin (LV)].
    Nagata H; Koike A; Kojima T; Ohiwa Y; Miwa M; Inamura Y; Matsumoto K; Suzumura K; Kanemitsu T; Naruse T
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2049-52. PubMed ID: 8215480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil].
    Yuasa C; Okabe H; Toko T; Takeda S; Unemi N
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1927-32. PubMed ID: 7487122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomodulation of 5-fluorouracil with antifolates.
    Bertino JR
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-52-S18-56. PubMed ID: 9420021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arterial infusion chemotherapy of 5-FU and leucovorin for patients with liver metastases from colorectal cancer].
    Yamamura T; Hanai A; Oikawa H; Matsuzaki H; Kikuchi K; Akaishi O; Seo K; Ozasa T; Katayama K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1516-9. PubMed ID: 8373209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid.
    Grem JL; Hoth DF; Hamilton JM; King SA; Leyland-Jones B
    Cancer Treat Rep; 1987 Dec; 71(12):1249-64. PubMed ID: 3319136
    [No Abstract]   [Full Text] [Related]  

  • 10. Another study of how to give fluorouracil?
    Saltz LB
    J Clin Oncol; 2003 Oct; 21(20):3711-2. PubMed ID: 12963699
    [No Abstract]   [Full Text] [Related]  

  • 11. [5-fluorouracil and low-dose leucovorin as surgical adjuvant therapy from viewpoint of long-term outcome].
    Hara A; Chung YS; Kawai M; Matsubara T; Satake K; Miyazaki H
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1173-7. PubMed ID: 9679580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of FU with high-dose folinic acid is effective for treatment of patients with gastric carcinoma.
    Machover D; Ulusakarya A; Goldschmidt E
    J Clin Oncol; 2008 Jan; 26(1):164. PubMed ID: 18165654
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer.
    Nobile MT; Barzacch MC; Sanguineti O; Chiara S; Gozza A; Vincenti M; Lavarello A; Cognein P; Lionetto R; Percivale PL; Bertoglio S; Murolo C; Esposito M; Vannozzi MO; Rosso R
    Anticancer Res; 1998; 18(1B):517-21. PubMed ID: 9568171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
    Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P;
    Br J Cancer; 2005 Jan; 92(1):24-9. PubMed ID: 15611795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.
    Aballéa S; Chancellor JV; Raikou M; Drummond MF; Weinstein MC; Jourdan S; Bridgewater J
    Cancer; 2007 Mar; 109(6):1082-9. PubMed ID: 17265519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of intra-arterial high-dose leucovorin and 5-FU including combination chemotherapy].
    Mitsuhata N; Matsuda T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3287-90. PubMed ID: 3490831
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients.
    Geisler J; Geisler SB; Lønning PE; Smaaland R; Tveit KM; Refsum H; Ueland PM
    Clin Cancer Res; 1998 Sep; 4(9):2125-8. PubMed ID: 9748129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folylpolyglutamate synthase and gamma-glutamyl hydrolase regulate leucovorin-enhanced 5-fluorouracil anticancer activity.
    Sakamoto E; Tsukioka S; Oie S; Kobunai T; Tsujimoto H; Sakamoto K; Okayama Y; Sugimoto Y; Oka T; Fukushima M; Oka T
    Biochem Biophys Res Commun; 2008 Jan; 365(4):801-7. PubMed ID: 18035049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.